ArticleFrontiers in cellular and infection microbiology2026
Lower respiratory tract microbiota characteristics in patients with
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Methods: Here, we performed 16S rRNA gene sequencing of bronchoalveolar lavage fluid collected from older adults with PAP at hospital admission and discharge, yielding 42 paired samples. We characterized longitudinal microbiota dynamics, identified candidate microbial biomarkers using LEfSe and random forest analyses, inferred functional profiles with Tax4Fun2, and compared microbiota-associated changes following meropenem-based therapy (n = 12) or levofloxacin-based therapy (n = 9). Results: PAP was associated with marked shifts in LRT microbial community structure, with post-treatment samples showing reduced Discussion: Collectively, these findings define the LRT microbiota landscape in elderly patients with PAP, nominate candidate microbial biomarkers, and indicate that antibiotic regimen is associated with distinct post-treatment microbial community structures, with potential implications for therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.